Cutler Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,700
Closed -$20K 5068
2020
Q3
$20K Buy
+14,700
New +$409K ﹤0.01% 2459
2019
Q4
Sell
-3,000
Closed -$2K 4218
2019
Q3
$2K Hold
3,000
﹤0.01% 3475
2019
Q2
$2K Sell
3,000
-30,000
-91% -$484K ﹤0.01% 3560
2019
Q1
$15K Buy
33,000
+26,800
+432% +$434K ﹤0.01% 2220
2018
Q4
$6K Hold
6,200
﹤0.01% 2832
2018
Q3
$13K Hold
6,200
﹤0.01% 2495
2018
Q2
$12K Sell
6,200
-4,000
-39% -$75.6K ﹤0.01% 2535
2018
Q1
$26K Sell
10,200
-24,500
-71% -$474K ﹤0.01% 2093
2017
Q4
$144K Buy
34,700
+3,000
+9% +$55.2K 0.01% 1157
2017
Q3
$114K Buy
31,700
+1,900
+6% +$25.7K ﹤0.01% 1562
2017
Q2
$28K Buy
29,800
+12,000
+67% +$160K ﹤0.01% 3070
2017
Q1
$30K Sell
17,800
-4,600
-21% -$58.1K ﹤0.01% 2899
2016
Q4
$14K Buy
22,400
+13,600
+155% +$149K ﹤0.01% 3832
2016
Q3
$11K Buy
8,800
+2,200
+33% +$22.5K ﹤0.01% 4103
2016
Q2
$4K Sell
6,600
-16,700
-72% -$165K ﹤0.01% 5135
2016
Q1
$32K Sell
23,300
-3,300
-12% -$31.1K ﹤0.01% 2775
2015
Q4
$39K Buy
+26,600
New +$424K ﹤0.01% 2725

Other funds holding HALO

Cutler Group's HALO Position: Q1 2021 in Review

Cutler Group sold out of Halozyme (HALO) in Q1 2021, closing a stake of 5,500 shares — an estimated $234K sold.

Cutler Group first reported a position in HALO in Q4 2015 and held it in 18 quarters. The position peaked at $423K in Q4 2015. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • Cutler Group reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 5,500 Halozyme shares in Q1 2021, an estimated $234K.
  • Cutler Group first reported a position in Halozyme in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Halozyme position peaked at $423K in Q4 2015.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.